The BBD data were analyzed using contour and 3D plots to elucidate the independent variables' effects
Quick Answer: Weight gain on Zepbound in women may result from inadequate dosing during early treatment, hormonal fluctuations, temporary fluid retention, compensatory eating behaviors, or underlying medical conditions rather than medication failure
Ready to Start Your Semaglutide Journey with MedHealth 360
These results represent significant clinical benefit, but they also reveal important variability: roughly 20-30% of participants achieved weight loss below 5%, while others exceeded 15% reduction
However, no submissions were approved by Health Canada yet, despite some being filed nearly two years ago
When combined with proper diet and exercise, TRT and GLP-1 medications can play a crucial role in promoting weight loss, improving metabolic health, and enhancing overall well-being